ExpreS2ion will present fourth quarter and full-year 2022 results
Hørsholm, Denmark, February 13, 2023 – ExpreS2ion Biotech Holding AB (“ExpreS2ion") is pleased to announce that it will present fourth quarter and full-year 2022 results via webcast on February 15th, 2023, at 14:30 CET.
By attending relevant industry and investor events, the company aims to increase the awareness of the ExpreS2 technology platform and its exciting development pipeline, including the novel ES2B-C001 HER2-cVLP breast cancer vaccine. More information on each event and how to register is found below and on the Company’s website.
Presentation of fourth quarter and full-year 2022 results hosted by HC Andersen Capital, February 15th, 2023 at 14:30 CET, Virtual
ExpreS2ion CEO Bent U. Frandsen and CFO Keith Alexander will discuss the fourth quarter and full-year 2022 results and answer investors’ questions. More information and registration can be found on the H.C. Andersen Capital Events website.
Certified Adviser
Svensk Kapitalmarknadsgranskning AB
